1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NJSave Programs is sponsored by New Jersey Department of Human Services, Division of Aging Services. NJSave is an online application that helps low-income older adults and individuals with disabilities determine eligibility and apply for various savings and assistance programs, including Pharmaceutical Assistance to the Aged and Disabled (PAAD), Senior Gold Prescription Discount Program, Lifeline Utility Assistance, and Medicare Savings Programs.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Low-income older adults and individuals with disabilities residing in New Jersey. Specific eligibility criteria vary for each program accessed through NJSave. Confirm the full requirements in the official notice before applying.
NJSave Programs is funded by New Jersey Department of Human Services, Division of Aging Services. Verify program details on the funder's official page before applying.
This opportunity targets applicants in New Jersey. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read article